SynopsisAlmotriptan is a serotonin 5HT-1B/1D-receptor agonist used to treat migraine. The global Almotriptan Malate Reagent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast perio.....
SynopsisAlogliptin Benzoate is one DPP-4 inhibitor which can be used to slow the inactivation of incretin hormones GLP-1 and GIP. The global Alogliptin Benzoate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witness.....
SynopsisAlogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase. The global Alogliptin Benzoate Reagent market was.....
SynopsisAzilsartan medoxomil (trade name Edarb) is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. It is indicated for the treatment of hypertension to lower blood pressure which redu.....
Synopsis Azilsartan medoxomil is a prodrug form of azilsartan, a potent and selective angiotensin II receptor 1 antagonist. The global Azilsartan Medoxomil Reagent market was valued at US$ million in 2023 and is anticipated to reach US$ million.....
SynopsisBromocriptine, an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary tumors, Parkinson’s disease (PD), hyperprolactinaemia, neuroleptic malignant syndrome, and type 2 diabetes. The global Bromocriptine Mesylate API mark.....
SynopsisBromocriptine mesylate is the mesylate salt of Bromocriptine. It is a dopamine receptor agonist. It is a derivative of the ergotoxin group of ergot alkaloids. The global Bromocriptine Mesylate Reagent market was valued at US$ million in 2023 and is antic.....
SynopsisCholine Fenofibrate is a choline salt of fenofibric acid used to lower low-density lipoproteins and very low-density lipoproteins while increasing high density lipoproteins. The global Choline Fenofibrate API market was valued at US$ million in 2023 and .....
SynopsisCholine fenofibrate is a newly developed choline salt of fenofibric acid, a synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity that acts as an PPARα agonist. The global Choline Fenofibrate Reagent market was valued at US$ million.....
SynopsisDoxycycline monohydrate is a tetracycline antibiotic used to treat many different bacterial infections, such as urinary tract infections, acne, gonorrhea, and chlamydia, periodontitis (gum disease), and others. The global Doxycycline Monohydrate API mark.....








